Hearology®
Research

CLIC5 gene therapy protects hearing and balance in mice

Gene therapy targeting CLIC5 preserved inner ear hair cells in animals, offering hope for treating inherited hearing and balance disorders.

Written by
HearologyThe Hearology team
Medically reviewed by
Micaela StonestreetBA (Speech Pathology and Audiology), MA (Aud), HCPC registered
Published9 January 2026
Updated17 November 2026
Read time3 min
An illustration shows a DNA double helix with a segment being replaced or modified, connected by lines to three circular icons depicting a brain, an eye, and red blood cells.
On this page ▾

Key takeaways

  • Researchers protected inner ear hair cells in mice that lack a working CLIC5 gene.
  • It was an animal study published in 2025, so there are no human results yet.
  • A self-complementary AAV vector worked as well as a standard one at a lower dose.
  • Genetic factors cause up to 60% of congenital and early-onset hearing loss, according to NIDCD.
  • Hearing aids and cochlear implants remain the usual options for permanent hearing loss.

Researchers at Tel Aviv University and in the US have used gene therapy to protect the inner ear’s hair cells in mice that lack a working CLIC5 gene. The treatment preserved both hearing and balance in the animals1. It has not been tested in people, and no gene therapy for CLIC5 hearing loss is available.

The work, led by Professor Karen Avraham of Tel Aviv University with collaborators at Boston Children’s Hospital and Harvard Medical School, was published in EMBO Molecular Medicine in 2025. The CLIC5 gene helps keep the hair cells that enable hearing and balance stable.

How common is genetic hearing loss?

The World Health Organization projects that nearly 2.5 billion people will have some degree of hearing loss by 2050, and more than 700 million will need hearing rehabilitation2. Genetic factors cause up to 60% of congenital and early-onset hearing loss3.

Balance problems that start in the inner ear can also make everyday life harder. Current treatments such as hearing aids and cochlear implants help people hear but do not stop the hair cells being lost. A therapy that works at the genetic level might one day change long-term outcomes for some people, if it proves safe and effective in humans.

How does the CLIC5 gene therapy work?

The CLIC5 gene supports the structure of the hair cells that enable hearing and balance. When the gene is faulty, these cells deteriorate, causing hearing loss first and balance problems later.

The new therapy uses a self-complementary adeno-associated virus (scAAV) to deliver a healthy copy of the gene. In mice, it worked as well as a conventional single-stranded vector at a lower dose, prevented hair cell degeneration and preserved both hearing and balance1.

What could this mean for people?

Because the inner ear’s hearing and balance systems share vulnerable cell structures, a therapy that stabilises hair cells might one day help prevent or delay both sensorineural hearing loss and balance disorders linked to CLIC5. That is a hope, not a result: it has not been shown in people.

If it works in humans, early treatment could matter most for children born with these genetic changes, but researchers would first need to show it is safe and effective. For now, hearing aids and cochlear implants are the usual options for permanent hearing loss4. You can read about the first gene therapy approved for a genetic form of deafness in our article on DB-OTO gene therapy, and about the wider gene therapy research.

What do audiologists say?

“This work presents an exciting possibility in a growing body of research into stem cell and genetic therapies for hearing loss,” said Micaela Stonestreet, a Clinical Audiologist at Hearology. “If similar results emerge in human trials, we could see a meaningful shift from managing symptoms to preventing progression.”

If you are worried about your hearing today, a hearing test is the first step, and the right help depends on the cause.

Share this article
Struggling to follow conversations?

Check your hearing for free

A free hearing screening with a clinician, who explains your results in plain English.

Book nowRead more
  • Same-day availability
  • Results explained in plain English

Frequently asked questions

What is the latest treatment for hearing loss?
It depends on the cause. Earwax and ear infections can be treated directly, and permanent hearing loss is usually managed with modern hearing aids or, when it is severe, a cochlear implant. Gene therapy is the newest area: in April 2026 the US approved the first one, for a rare genetic type. Others, like this CLIC5 work, are still in the lab.
Will there be a cure for hearing loss in the future?
Researchers are working on it, and progress is real, but it is likely to come type by type rather than as one cure. Gene therapies are being developed for specific inherited forms, and other teams are studying ways to protect or regrow hair cells. For now, hearing aids and implants work well for most people, so there is no need to wait.
Is there gene therapy for hearing loss?
For a very small group, yes. In the US, a gene therapy for deafness caused by the OTOF gene was approved in 2026. Several others are in clinical trials. The CLIC5 therapy in this article has only been tested in mice so far, so it is not available to anyone yet.
What is the CLIC5 gene?
CLIC5 is a gene that helps keep the tiny hair cells in the inner ear stable. These cells turn sound into signals for the brain and also help with balance. When CLIC5 is faulty, the cells slowly break down, usually causing hearing loss first and balance problems later. It is a rare cause of inherited deafness.

References:

  1. [1] R. Hahn, S. Taiber, O. Shubina-Oleinik, G. S. G. Géléoc, J. R. Holt, and K. B. Avraham, "AAV gene therapy rescues hearing and balance in a model of CLIC5 deafness," EMBO Molecular Medicine, vol. 17, no. 9, pp. 2233-2257, Sep. 2025, doi: 10.1038/s44321-025-00275-7. [Online]. Available:
  2. [2] World Health Organization, "Deafness and hearing loss," WHO fact sheet. Accessed: Nov. 15, 2026. [Online]. Available:
  3. [3] National Institute on Deafness and Other Communication Disorders, "The future of gene therapy for hearing loss," NIDCD. Accessed: Nov. 15, 2026. [Online]. Available:
  4. [4] NHS, "Hearing loss," NHS website. Accessed: Nov. 15, 2026. [Online]. Available:
Author
Written by HearologyThe Hearology team
Medically reviewed by
Micaela StonestreetBA (Speech Pathology and Audiology), MA (Aud), HCPC registeredClinical Operations Manager & Clinical AudiologistReviewed 9 January 2026
Keep reading

More in Research

ResearchStudy links ADHD listening difficulties to brain networks3 min read
ResearchDB-OTO gene therapy for inherited deafness: what the trial found3 min read
ResearchChildhood deafness gene therapy trial passes safety check3 min read
More Research articles →